Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2021 - 12 - 06 save search
Taysha Gene Therapies Announces Late-Breaking Abstract and Poster Presentation on Positive Preclinical Data For TSHA-105 Demonstrating Therapeutic Potential for the Treatment of Epilepsy Caused by SLCA13A5 Deficiency
Published: 2021-12-06 (Crawled : 23:00) - biospace.com/
TSHA | $2.41 -4.74% 230K
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: 0.0%
treatment presentation preclinical gene therapies potential positive gene therapy pre-clinical
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome
Published: 2021-12-06 (Crawled : 22:00) - biospace.com/
ACAD | News | $16.66 -0.48% 190K
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
trial positive results phase 3 syndros topline rett syndrome
Carpenter Technology Names Suniti Moudgil to the Position of Chief Technology Officer
Published: 2021-12-06 (Crawled : 22:00) - globenewswire.com
CRS | $78.69 -2.26% 130K
|
Non-Energy Minerals
|
| O: 3.16%
H: 2.63%
C: -0.98%
technology positive
Inventiva announces positive results of clinical thorough QT study conducted with lanifibranor
Published: 2021-12-06 (Crawled : 21:00) - inventivapharma.com
IVA | $3.12 -5.17% 10K
|
Health Technology
|
| O: 1.1%
H: 0.47%
C: -0.8%
positive results positive results
Bsense Announces Positive Topline Proof-of-Concept Preclinical Data that Supports the Development in Additional Sensory Hyperexcitability Related Disorders
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: 0.0%
sensor order preclinical positive topline pre-clinical
Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy
Published: 2021-12-06 (Crawled : 14:30) - biospace.com/
ACET | News | $1.94 -7.62% 800K
|
Health Technology
|
| O: 39.29%
H: 0.0%
C: 0.0%
positive therapy
Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at Market
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
BLCM | $0.0748 381.28% 6.1K
|
Health Technology
|
| O: -3.01%
H: 5.59%
C: -0.62%
car-t phase 1 positive
Biohaven Reports Positive Topline Results from Pivotal Migraine Trial of Intranasal Zavegepant Demonstrating Ultra-Rapid Pain Relief by 15 minutes; Prepares for Submission of New Drug Application
Published: 2021-12-06 (Crawled : 13:30) - biospace.com/
BHVN | News 0 d | $38.425 -2.99% 260K
|
Health Technology
|
| O: -5.67%
H: 0.0%
C: 0.0%
new drug application drug trial migraine topline results positive results topline pain relief submission
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $2.05 75.21% 78M
|
AMST | $3.2 60.0% 63M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.05 44.75% 13M
|
Technology Services
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $27.91 28.5% 8.9M
|
Finance
WHLM | $6.43 26.58% 580K
|
Commercial Services
Your saved searches
Save your searches and get alerts when important news are released.